JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 50 filers reported holding JANUX THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,526,956 | +16.6% | 1,639,579 | +37.3% | 0.00% | – |
| Q2 2023 | $14,179,758 | +3.3% | 1,194,588 | +5.3% | 0.00% | – |
| Q1 2023 | $13,729,205 | -5.5% | 1,134,645 | +2.9% | 0.00% | – |
| Q4 2022 | $14,527,234 | -14.2% | 1,103,055 | -11.8% | 0.00% | -100.0% |
| Q3 2022 | $16,929,000 | +14.7% | 1,250,348 | +3.5% | 0.00% | – |
| Q2 2022 | $14,754,000 | -11.4% | 1,208,354 | +4.0% | 0.00% | – |
| Q1 2022 | $16,659,000 | -16.3% | 1,161,721 | +15.2% | 0.00% | -100.0% |
| Q4 2021 | $19,892,000 | +14.7% | 1,008,261 | +25.8% | 0.00% | – |
| Q3 2021 | $17,341,000 | +532.2% | 801,778 | +629.2% | 0.00% | – |
| Q2 2021 | $2,743,000 | – | 109,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |